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G-quadruplex DNA Aptamers and their Ligands: Structure, Function and Applica-
tion 
W.O. Tucker, K.T. Shum and J.A. Tanner* 
Department of Biochemistry, University of Hong Kong, Pokfulam, Hong Kong, China  
Abstract: Highly specific and tight-binding nucleic acid aptamers have been selected against a variety of molecular targets for over 20 
years. A significant proportion of these oligonucleotides display G-quadruplex structures, particularly for DNA aptamers, that enable mo-
lecular recognition of their ligands. G-quadruplex structures couple a common scaffold to varying loop motifs that act in target recogni-
tion. Here, we review DNA G-quadruplex aptamers and their ligands from a structural and functional perspective. We compare the diver-
sity of DNA G-quadruplex aptamers selected against multiple ligand targets, and consider structure with a particular focus on dissecting 
the thrombin binding aptamer – thrombin interaction. Therapeutic and analytical applications of DNA G-quadruplex aptamers are also 
discussed. Understanding DNA G-quadruplex aptamers carries implications not only for therapeutics and diagnostics, but also in the 
natural biochemistry of guanine-rich nucleic acids.  
Keywords: G-quadruplex, aptamer, thrombin, sclerostin, G-quartet, G4 tetrad, SELEX. 
INTRODUCTION 
 The artificial selection of nucleic acid aptamers from a large 
pool of random sequences that bind specifically to a molecular 
target was first demonstrated contemporaneously by Tuerk & Gold 
and Ellington & Szostak in 1990 [1, 2]. Tuerk & Gold referred to 
the approach as systematic evolution of ligands by exponential 
enrichment (SELEX), whilst Ellington & Szostak first used the 
term ‘aptamer’ to describe the nucleic acids selected against a 
ligand in this manner Fig. (1). For both the original studies, selec-
tion was performed on RNA, which classically is assumed to have 
greater structural diversity than DNA due to the natural pucker in 
the ribose ring. The original pioneering studies selecting ligand-
binding RNA were soon followed up with the selection of single-
stranded DNA [3], demonstrating that DNA was able to bind targets 
in quite a similar manner to RNA. It was perhaps surprising the 
extent to which single-stranded DNA was able to demonstrate such 
structural plasticity, suggesting that DNA may also catalyze chemi-
cal transformations, and indeed the first deoxyribozyme was se-
lected and characterized in 1994 [4]. The classic view of proteins 
‘recognizing’ nucleic acids can be reframed in terms of aptamer 
selection: is it just as valid to consider nucleic acids ‘recognizing’ 
proteins? Single-stranded DNA can in ways be considered structur-
ally and functionally similar to RNA, and that functionality depends 
on structure. One important structure often observed within single-
stranded DNA aptamers is the G-quadruplex. Herein, we discuss 
the significance of the aptameric G-quadruplex and the roles it 
plays in molecular recognition by nucleic acid aptamers. 
 An aptamer-derived G-quadruplex was first observed in NMR 
studies on a thrombin-binding DNA aptamer [5], consisting of two 
tetrads of guanosine base pairs. This aptamer inhibited the throm-
bin-catalyzed polymerization of fibrinogen. It was shown that the 
G-quadruplex was critical for inhibitory activity as substitution of 
any of the guanines reduced the inhibition of thrombin [6]. Fur-
thermore, the X-ray crystal structure of this aptamer in complex 
with thrombin was solved showing the G-quadruplex aptamer sand-
wiched between two positively charged regions of two separate 
thrombin molecules [7] Fig. (2). Remarkably, this remains the only 
structure of a G-quadruplex aptamer selected by SELEX in com-
plex with its target. Since those original studies, the G-quadruplex  
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Fig. (1). Schematic of the SELEX process to select oligonucleotide ap-
tamers. A nucleic acid library is incubated with a target for binding. Un-
bound oligonucleotides are washed away, and bound ones are recovered 
with the target. The tight binding oligonucleotides are amplified by PCR. 
Repeated cycles of SELEX result in enriched sequences. After the last 
round, the selected aptamers are cloned and sequenced.  
 
has been observed time and again during DNA aptamer selections 
Table 1, clear evidence that the G-quadruplex is amongst the most 
common single-stranded DNA structures identified by in vitro se-
lection. The questions that then arise are: 1.) How do we classify G-
quadruplex structures selected from nucleic acid pools? 2.) How 
does the G-quadruplex have discriminatory ability given their pre-
ponderance in aptamers?  
 Not all G-rich sequences have the propensity to form G-
quadruplex structure but G-rich sequences are essential for G-
quadruplex formation. Metal ions and loop sequences connecting 
the guanosines also play critical roles in G-quadruplex formation. 
Experimental techniques to observe G-quadruplex structure in a 
nucleic acid include UV melting, polyacrylamide gel electrophore-
sis, fluorescent resonance energy transfer, sedimentation velocity 
analysis, cross-linking experiments, electron microscopy, atomic 
force microscopy and circular dichroism (CD). CD is the most 
comprehensive “broad-brush” technique to analyze G-quadruplex 
topology. More detailed quaternary structures of aptamers can be 
resolved by X-ray diffraction and nuclear magnetic resonance 
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Table 1. DNA G-quadruplex Aptamers: Targets, Sequences and Topologies 
Target  Sequence (5' to 3') Topology of G-Quadruplex Reference 
Protein targeted DNA G-quadruplex Aptamers 
Thrombin d(GGTTGGTGTGGTTGG) Anti-parallel G-quadruplex, monomer [15] 
Nucleolin d(GGTGGTGGTGGTTGTGGTGGTGGTGG) Anti-parallel G-quadruplex, dimer [16] 
Signal transducer and 




N.A. [17, 18] 
Human RNase H1 d(CGGTCGCTCCGTGTGGCTTGGGTTGGGTGTGGCAGTGA
C) 






Parallel G-quadruplex [20] 
VEGF d(TGTGGGGGTGGACGGGCCGGGTAGA) Anti-parallel G-quadruplex [21] 
HIV-1 gp120 V3 loop d(TTGGGTT) Parallel G-quadruplex, tetramer [22] 
HIV-1 gp120 V3 loop / 
CD4 binding site 
d(TGGGAG) Parallel G-quadruplex [23] 
HIV-1 integrase d(GGGGTGGGAGGAGGGT) Anti-parallel G-quadruplex, dimer [24] 
HIV-1 reverse transcrip-
tase  
d(GGGGGTGGGAGGGTAGGCCTTAGGTTTCTGA) Anti-parallel G-quadruplex, monomer [25] 
HIV-1 reverse tran-
scriptase  
d(CGCCTGATTAGCGATACTCAGCGTTGGGGGGGGGGGG) Anti-parallel G-quadruplex, monomer [26] 
HIV-1 nucleocapsid pro-
tein 
d(GGTTGGTGTGGTTGG) Anti-parallel G-quadruplex, monomer [27] 
HCV RNA dependent 
RNA polymerase 
d(GGGCGTGGTGGGTGGGGTACTAATAATGTGCGTTTG) Anti-parallel G-quadruplex monomer [28] 
SARS –CoV helicase d(AGCGGGCATATGGTGGTGGGTGGTATGGTC) Parallel G-quadruplex [14] 
M. tuberculosis polyphos-
phate kinase 2 
d(AACACATAGGTTTGGTTAGGTTGGTTGGTTGAATTA) Anti-parallel G-quadruplex [13] 
Sclerostin d(TTGCGCGTTAATTGGGGGGGTGGGTGGGTT) Parallel G-quadruplex [12] 
Insulin d(GGTGGTGGGGGGGGTTGGTAGGGTGTCTTC) Anti-parallel G-quadruplex, monomer [29] 
Non-protein targeted DNA G-quadruplex aptamers 
Hematoporphyrin IX d(ATGGGGTCGGGCGGGCCGGGTGTC) Anti-parallel G-quadruplex monomer [30, 31] 
Hemin d(GTGGGTAGGGCGGGTTGG) N.A. [32] 
Ochratoxin d(GATCGGGTGTGGGTGGCGTAAAGGGAGCATCGGACA) N.A. [33] 
Potassium ions d(GGGTTAGGGTTAGGGTAGGG) Anti-parallel G-quadruplex, monomer [34] 




(NMR). Computationally, Quadruplex forming G-rich Sequences 
(QGRS) mapper is a web-based computer program that can analyse 
putative G-quadruplex forming sequences based on the primary 
sequence input [8]. 
 G-quadruplex DNA aptamers have been observed after SELEX 
selection against a wide variety of targets – mainly proteins but also 
some other targets Table 1. The reader also interested in RNA G-
quadruplexes is pointed towards two other recent reviews [9, 10]. 
One possible reason that G-quadruplex aptamers tend to be selected 
is the significant charge density of G-quadruplex DNA – twice the 
negative charge per unit length when compared to double-helical 
DNA [11]. The consequent electrostatic potential provides for 
strong binding to positively charged surfaces of proteins, although 
hydrophobic interactions are also critical for strong and specific 
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binding to the target. G-quadruplex structures also tend to be se-
lected more often when performing selections using DNA libraries 
rather than RNA libraries, though this is perhaps unsurprising given 
RNA’s greater variety of structural topologies. G-quadruplex is one 
of only a few structural arrangements of DNA that involves sophis-
ticated tertiary folding. 
 Common selection of DNA aptamers against totally unrelated 
targets has strengthened the hypothesis that G-quadruplex aptamers 
can target a broad range of protein structures, yet retain specificity. 
Indeed, we have recently isolated and characterized DNA aptamers 
against three different classes of protein targets --- SARS-CoV 
helicase, M. tuberculosis polyphosphate kinase 2 and sclerostin [12-
14]. 
 SARS-CoV helicase is a nucleic acid binding protein, poly-
phosphate kinase 2 is a polyanion binding protein and sclerostin is a 
protein interacting protein. We also employed the same selection 
strategy to isolate tight binding sequences using a magnetic bead 
approach so that there is no bias on selecting aptamers. Unexpect-
edly, G-quadruplexes were discovered to be present in all aptamers 
selected against these protein targets. Except for the G-quadruplex 
SARS-CoV helicase aptamers, all displayed inhibitory effects 
against their respective protein targets [12-14]. Taken together with 
other G-quadruplex forming aptamers in Table 1, it can be surmised 
that the correlation between G-quadruplex forming aptamers and 
the class of protein they target is minimal.  
 G-quadruplex aptamers have some common interesting se-
quence characteristics. The most common base found between the 
guanosines is thymine, although adenosine and cytosine are also 
observed. Many G-quadruplex aptamers consist of guanosine and 
thymine alone, e.g. d(TGGG)n. Thymine is particularly favored as 
this base has a monocyclic pyrimidine and does not base-pair to 
guanosine. Substitution of thymine with adenosine tends to inhibit 
G-quadruplex structure because adenosine is made up of a bicyclic 
purine that is too bulky for the loop sequence connecting the G-
quadruplex. Substitution of thymine with cytosine tends to inhibit 
G-quadruplex structure due to the competition with surrounding 
guanosine for Watson and Crick base-pairing.  
 Additionally, G-quadruplexes may be classified into two to-
pologies - parallel and anti-parallel. Parallel G-quadruplexes con-
tain four strands of nucleic acids in the same direction; whilst anti-
parallel G-quadruplexes contain four strands of nucleic acids in 
opposite directions. The topology of G-quadruplex is usually de-
termined by circular dichroism. Aptamers validated to have G-
quadruplex structure usually do not have a defined topology. Actu-
ally, the mechanism by which a G-rich sequence folds into parallel 
or anti-parallel topology remains elusive, and so far no general rule 
has been reported to accurately predict the topology of a particular 
G-rich sequence. The folding of G-quadruplex can be controlled by 
a variety of factors, including but not limited to metal ions, loop 
sequence, and number of consecutive G-quartets. Since there are 
many possible structural arrangements of G-quadruplex structures 
(parallel, anti-parallel, unimolecular, bimolecular and tetramolecu-
lar), G-quadruplex structure, originally conceived as a simple rigid 
motif, actually exhibits remarkable diversity [11]. Such molecular 
diversity of G-quadruplex aptamers with a similar scaffold can 
explain the high specificities and binding affinities towards their 
targets. 
G-QUADRUPLEX APTAMER STRUCTURE AND STABIL-
ITY 
 The structure and stability of G-quadruplex oligonucleotides in 
a given environment was first investigated by studying short se-
quences derived from telomeric repeats and motifs [36]. Interest in 
naturally derived G-quadruplexes has since grown considerably, 
which is not surprising given the plethora of G-quadruplex forming 
sequences in telomeres, promoter regions, RNA transcripts, and 
immunoglobulin switch regions [37-39]. Since the discovery of G-
quadruplexes in SELEX-derived sequences, similar techniques and 
approaches have been applied to understand G-quadruplex forma-
tion in DNA and RNA aptamers [7]. Examples of G-quadruplex 
forming aptamers and biophysical characterization of G-quadruplex 
aptamers have been reviewed [11, 37, 40]. In recent years, impor-
tant research has focused on understanding G-quadruplex stability 
and structure through backbone, sugar, and nucleobase substitutions 
and modifications in the aptamer sequence, yet have not been sum-
marized formally.  
 The best characterized aptamer in the sense of structure and 
stability is a 15nt thrombin binding aptamer (TBA) which targets 
human alpha-thrombin [15]. TBA was SELEX enriched to the con-
sensus sequence d(GGTTGGTGTGGTTGG) which was found to 
inhibit thrombin activity [15]. Thrombin, the serine protease which 
converts fibrinogen into clottable fibrin in the hemostasis process, 
importantly contains an anion binding recognition exosite I (fi-
brinogen binding) and exosite II (heparin binding) [7, 41-43]. It is 
these two sites that are most vital to the complex with TBA. To 
illustrate one of these sites a distant view of TBA interaction with 
exosite I based on X-ray structure is shown in Fig. (2a), with a 
closeup of TBA in Fig. (2b). Although NMR data does differ from 
X-ray crystal structure data in observing how the loops interact with 
the mentioned thrombin domains, it is well established that TBA 
interacts with two thrombin molecules while inhibiting only one [7, 
41-43]. In its interaction with exosite I, three thrombin amino acid 
residues form ion pairs with TBA as T7 and T9 associate with a 
hydrophobic cluster as shown in Figs. (2c and 2d).  
 The debate over TBA’s molecularity in solution has been a 
central theme since the beginning of its characterization [5-7, 42, 
44-52]. The general consensus was derived from structural work in 
the 1990s which observed TBA as an anti-parallel unimolecular 
quadruplex with a chair-like intramolecular structure under physio-
logical conditions [7, 42]. However, a recent study provided evi-
dence that TBA can be bimolecular and parallel in various salt con-
ditions [44]. Circular Dichroism (CD) showed this phenomenon 
was dependent on aptamer concentration [44]. In addition, length-
ening of loop regions and/or the 5' end resulted in strengthening the 
preference of the modified aptamer for the intramolecular state as 
compared to the parent TBA [44]. This work illustrated that the 
physical state of TBA depends on several variables including bind-
ing to thrombin and stabilizing cations [69]. When destabilized, 
TBA is suggested to denature first by breaking G-G base pairing 
followed by opening of the TGT then TT loops in an exothermic 
process [51, 65]. Hence, insight into the mechanisms of folding and 
binding has been gained by atomic substitutions in the TBA back 
bone, sugars or bases. Because of its promise in clinical applica-
tions, TBA has been a focus of attention to better understand its 
stability and improve its usefulness.  
 Two key variables relating to structure and stability of TBA, as 
well as other G-quadruplexes, are the anti or syn glycosyl torsion 
angles of the bases relative to the sugars, as well as the C2'- or C3'-
endo sugar pucker conformations in the case of RNA Fig. (3). It is 
well established that deoxyriboguanosines generally favor the syn 
conformation while riboguanosines favor the anti, but this is not 
absolute considering that other factors such as sugar pucker influ-
ence the conformation [66]. It follows that DNA oligonucleotides 
favor anti-parallel topology, whereas RNA oligonucleotides favor 
parallel [66]. For DNA, the anti or syn conformations, also known 
as glycosidic bond angles (GBA), can have 16 different positions, 
and there are 26 permissible looping conformations [70]. The rules 
governing the relationship between the GBA, loops, strand polarity, 
and groove were excellently summarized in 2007 [70]. In the anti-
parallel strands of TBA, four of the guanines have syn conformation 
while four have anti in an alternating pattern [5, 6, 46, 71]. In a 
recent illustration of the importance of the syn or anti conforma-
tions of the G-quadruplex, substitution of several dG residues with 
rG caused conversion back and forth from anti-parallel to parallel 
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quartets Fig. (4f) [66]. In these experiments, circular dichroism and 
PAGE revealed the aptamers were bimolecular and parallel, likely 
to be a single quadruplex composed of two strands [66]. Overall, 
this work clearly showed the importance of nucleoside conforma-
tional preferences to the formation of G-quadruplex and conse-
quences on topology. Also recently, by employing methanocarba-
nucleosides, anti or syn conformations were biased so as to under-
stand the importance of the conformations to the stability of TBA 
[65]. It was found that changing the conformation at G15 especially 
destabilized the G-quadruplex aptamer and changes at G14 greatly 
disrupted the structure at large [65]. This study validated the use of 
locked nucleic acids to deduce the importance of sugar pucker and 
nucleobase orientation in a given G-quadruplex structure. In an-
other approach, stabilization of TBA was attempted by introducing 
2?-deoxy-2?-fluoro-D-arabinonucleic acids into bases to deliberately 
confer either the syn or anti conformations Fig. (4g) [67]. 2?F-ANA 
conformationally biases the sugar pucker to C2'-endo thus favoring 
the anti conformation. Using UV thermal melting and CD studies, it 
was observed that replacement with anti-dGs into TBA stabilized 
the aptamer whereas insertion of 2?F-ANA at the location of syn-
dGs destabilized the aptamer [67]. 
 Some recent studies have focused on conformational flexibility. 
In one example, TBA was substituted with single unlocked nucleic 
acid monomers at every possible position in the 15 residue chain, 
thus providing the molecule with more plasticity Fig. (4e) [41]. UV 
melting analysis and kinetic studies revealed that substitution at 
various residues made folding more energetically favorable, while 
substitution of others were unfavorable and diminished thrombin 
binding [41]. Blood clotting ability also either decreased, or in one 
substitution, increased. These substitutions concluded mostly what 
was expected: introducing more flexibility in the quadruplex form-
ing residues and loop regions generally decreased stability and 
binding, but insertion of a modification at certain locations can have 
some unexpected advantages. Another study introduced the more 
rigid modification of thiophosphoryl internucleotide bonds in the 
chain backbone, which were placed at loop regions of TBA to de-
crease flexibility and endowed TBA with increased thermostability 
Fig. (4c) [60]. As expected, stability decreased when substitutions 
were made in the planar regions. Comparing this with the decrease 
in thermo stability from unlocked nucleic acids in the loop region 
confirms the importance of loop rigidity to the overall stability of 
the TBA molecule [41]. Another example that employed locked 
nucleic acids showed by NMR, CD, pro-thrombin assays, and struc-
tural calculations, that the single LNA modifications changed only 
the sugar pucker but not the anti/syn conformations which ulti-




















Fig. (2). Three-dimensional crystal complex of thrombin binding aptamer (TBA) bound to thrombin. Figures were prepared using Pymol based on PDB 
file 1hut [7]. a: Electrostatic surface potential representation of thrombin bound to TBA. b: Close-up view of the structure of TBA. c: Front face view of im-
portant amino acids involved in the thrombin-TBA interaction. d: Rear face view of important amino acids involved in the thrombin-TBA interaction.  
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 The nucleobases are directly responsible for the interactions 
that comprise the G-quadruplex, and hence full nucleobase substitu-
tions have also been investigated. In one alternative approach to 
aptamer enrichment (SELEX), a randomly substituted isoguanine 
(iG) library of the TBA sequence was screened against human al-
pha thrombin and binding species were sequenced and synthesized 
Fig. (4a) [55]. When incorporated into particular planar sequences, 
isoguanine can form a pentamer association around a monovalent 
cation, whereas guanines can only form tetramers in the quadru-
plex. Two iG substituted aptamers were found to have substantially 
higher binding affinities than the parent as determined using Iso-
thermal Titration Calorimetry (ITC), albeit not due to pentamer 
forming sequences [55]. In contrast, substitution of only one of the 
Gs in the quadruplex with 6-thioguanine prohibited quadruplex 
formation entirely Fig. (4h) [68]. This was more dramatic than 
expected, as in some cases quadruplexes can still form with inosine 
substitutions [72] In a more comprehensive study, systematic 
changes were made to the backbone, bases, and sugars Fig. (4) [58]. 
It was found that changing T’s to U’s had a stabilizing effect, loss 
of negative charge in the backbone had a destabilizing effect, and 
hydrogen bond capacity at the 2' position of the ribose was shown 
to be of particular importance [58]. In an exclusively computational 
approach, structure activity relationships of a photo-labile caged 
TBA aptamer were performed assuming the analogue at the 6th 
guanosine position Fig. (4a) [53]. Simulations revealed distortions 
due to the caged TBA which manifested in the loop regions, Hoog-
steen binding of guanosines, central monovalent cation positioning, 
and base stacking. Upon removal of the photo-labile group, a de-
crease in groove length and G10 in particular contributed the most 






Fig. (3). Ribose conformations as key determinants of G-quadruplex stability. Left: C2'-endo (also known as South, S) and C3'-endo (also known as 






































Fig. (4). Chemistry of guanosine substitutions in the study and/or stabilization of G-quadruplex aptamers. (a) (from left to right) dGNPP [53], 4-thio-
deoxyuridylate [54], Iso-guanine [55], Adenine [48, 56, 57], Thymine [48, 57, 58], Cytosine [57], and Uracil [57, 58], (b) 5’-5’ inversion [59], (c) Sulphur [58, 
60] and methyl [58], (d) Locked Nucleic Acid (LNA) [61-63], (e) (from left to right) Unlocked Nucleic Acid (UNA) [41], N(1)-(3-hydroxy-2-hydroxymethyl-
2-methylpropyl)-thymidine [64], Methanocarba dG north (upper) and south (below) [65], (f) Hydroxyl [58, 66] and Methoxy [58], (g) Fluorene [67] and (h) 
Sulphur [68].  
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 In one example which involved an alternative to replacing spe-
cific bases in some way, a 5'-5' inversion was introduced to TBA, 
thus named mTBA d(3'GGT 5'-5'TGGTGTGGTTGG 3') Fig. (4b) 
[73]. NMR and CD studies revealed this modification to have three 
strands in the same direction and one strand in the opposite direc-
tion, which may be the reason for its increased thermal stability 
[73]. Human plasma assays showed a reduced biological activity 
however. Two years later the same group used Differential Scan-
ning Calorimetry (DSC) and ITC to better understand the inverted 
TBAs (mTBA) interaction with thrombin [59]. The greater stability 
of mTBA was attributed to its greater enthalpy value, which may 
suggest additional hydrogen bonding. The 1:2 stoichiometry of 
aptamer to thrombin was also reconfirmed with the ITC experi-
ments [59]. Recently, the crystal structure of mTBA with thrombin 
was solved [74]. By virtue of a higher resolution (2.15-Å vs. 2.9-
Å), the model for mTBA binding to thrombin was clarified. This 
structural study revealed that both hydrophilic and hydrophobic 
interactions contribute to binding, including interactions mediated 
by leucine, isoleucine, and glutamic acid. More significant hydro-
gen bonding is involved between the TT loops of mTBA binding 
exosite I as compared to TBA, helping to explain its higher affinity. 
 The two lateral TT loops and central TGT loops of TBA have 
also been the target of modifications specifically in order to put 
their role into context. To this end, loop regions were substituted for 
other nucleotides, extra nucleotides were inserted and some were 
truncated in order to study the thermodynamic stability using UV 
melting curves and DSC [48]. The thermodynamic profiles indi-
cated that different loop sequences and compositions significantly 
affects stability and the TGT loop in particular. Later, both loops 
were individually substituted with acyclic thymines, which shortens 
the distance between the base and phosphate, introduces more hy-
drophobicity, and creates a chiral center [64]. Structural informa-
tion was compared to biological activity using NMR, UV, CD, 
Prothrombin Time (PT), and Fibrinogen Clot Assays. A correlation 
was seen between structure and activity as they pertain to substitu-
tions in the TGT loop [64]. Further, it was concluded that substitu-
tions at T3 and T12 have little effect whereas substitutions at T4 
and T13 destabilize which was presumed to be due to the loss of a 
hydrogen bond between the two residues. T3 or T4 substitutions 
were also shown to have less biological activity than T12 or T13 
substitutions, implicating the importance of the 5' TT loop in the 
inhibition mechanism [64]. Alternative nucleotides, extra thymines 
and 2-aminopurine were substituted into the loops [57]. DSC and 
CD techniques were used and thermodynamic parameters for the 
loops were subtracted from that of one G-quartet stack. The loops 
were discovered to contribute to the stability due to favorable heat 
contributions and unfavorable entropy, with all loop changes lower-
ing overall stability [57]. Most recently, the thermal stability of 
TBA was measured in the context of thrombin binding while ex-
changing loop thymines with adenines [56]. It was concluded that 
the loop regions which hydrogen bond to thrombin and bind the 
intramolecular cation are likely to indirectly stabilize the G-
quadruplex.  
 Finally, a few recent papers have investigated the consequences 
of TBA substitutions on biological activity and physiological stabil-
ity. A near 3-fold decrease in IC50 was seen as compared to TBA 
using thrombin clotting activity assay when various thymines at the 
3,7,9, and 13 positions were substituted with 4-thio-deoxyuridylate 
Fig. (4a) [54]. A similar increase in the modified aptamers’ inhibi-
tion in plasma and an increase in platelet activation was observed as 
well [54]. Structural and thermal stability information would be 
helpful to better understand the mechanism behind the inhibition as 
it seems the only point of reference available is previously men-
tioned work in which single thio-substituted dGs strongly destabi-
lized TBA [68]. Moreover, in order to compare TBA thermal stabil-
ity and topology with a clotting activity assay, locked nucleic acids 
were used at G2, T4, G5, T7, and T8 positions Fig. (4d) [62]. The 
biological activity and stability did not appear to correlate, although 
conditions used in stability studies are often dramatically different 
from those in activity assays. The TGT loop, rather than overall 
stability, was implicated in effecting biological activity most sig-
nificantly [62]. As for nuclease resistance with regard to TBA, one 
recent paper attempted capping the 3' end with various 2' and 4' 
bridged nucleotides Fig. (4d) [63]. These sugar modifications 
showed a several-fold increase in nuclease resistance in both phos-
phodiesterase assay and human serum while maintaining binding 
ability as shown in capillary electrophoresis [63]. 
 Overall, various recent studies have elucidated the conse-
quences of changes made to the various structural regions of TBA 
which may pertain to similar structural motifs also. Understanding 
the states of the anti/syn or sugar pucker conformations has proven 
to be useful in explaining causes of the potential loss of hydrogen 
or ionic bonding. Through the replacement of dG with rG residues 
[66], the employment of methanocarba-nucleosides [65], and the 
use of 2’F-ANA [67], the rules of quadruplex formation as pro-
posed theoretically by Webba da Silva were understood using the 
real example of TBA [70]. The introduction of increased flexibility 
or rigidity with unlocked [41] or locked nucleic acids [61] has pro-
vided insight into the key regions of the sequence that provide the 
most stability. Base substitutions have also provided a greater un-
derstanding of overall stability and formation [53, 58]. Importantly, 
a superior functional aptamer was created by introducing a 5’-5’ 
inversion [59, 74]. Finally, significant perturbations to the loops 
have also provided some illustration of their contribution to the 
overall topology, which can be compared to the proposed rules of 
G-quadruplex formation - at least for a chair-like, one quadruplex 
stack DNA aptamer conformation [48, 56, 57, 66, 70]. It is hoped 
that such a diverse panel of changes be instigated for other parent 
aptamers so comparisons can be made in the future. 
EFFECTS OF CATIONS ON G-QUADRUPLEX APTAMER 
STRUCTURE AND STABILITY – THE CASE STUDY OF 
TBA 
 G-quadruplex topology and stability was first understood from 
the perspective of telomeric sequences, and from these examples 
some generalities were drawn such as: 1) cation ability to induce 
quadruplex formation follows the trend K+>Rb+>Na+>Cs+>Li+ with 
mechanistic differences being the most understood between K+ and 
Na+, 2) many cations move in and out of the quadruplex core if not 
obstructed, 3) Ka values for divalent cations are significantly greater 
than those for monovalent cations and 4) stabilizing abilities of 
divalent cations relate in the order Sr2+>Ba2+>Ca2+>Mg2+ [40]. A 
number of studies have investigated the influence of cations on 
DNA aptamer structure, and TBA is again the most deeply studied 
model for this aspect of aptamers that can act as a case study. Not 
only do cations have an important role in stabilizing quadruplex 
aptamers, but this property has even been exploited for the purpose 
of cation detection. The TBA aptamer itself has also been used to 
detect Hg2+ and Pb2+ [75]. As a further example, aptamers have 
been generated for the detection of K+ using fluorometric and 
nanosilver resonance scattering methods [76, 77]. To some degree, 
these detection methods owe their approach to previous work in 
understanding the relationship between cation and DNA G-
quadruplex aptamer.  
 G-quadruplexes owe their remarkable stability to a conglomera-
tion of forces including hydrogen bonding, Van der Waals, stack-
ing, hydrophobic, and ionic interactions. More unique, however, is 
the stability cations lend themselves to quadruplex structure, which 
is thought to be due to an association with O6 carbonyl groups be-
tween the planes [78, 79]. In the case of aptamers however, and for 
TBA in particular, the placement of the stabilizing cation is still 
debated [49, 80]. Also central to the discussion of TBA is the de-
pendence on, and stoichiometry of, different cations which are of 
special interest for those cations available under physiological con-
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ditions. Some of the initial structural work on TBA asserted that 
TBA depends on cations such as potassium for its chair-like active 
fold [5, 6, 46, 81-83]. TBA was assessed using NMR in the pres-
ence of Na+ and K+ [81]. In this study 100 mM Na+ alone showed 
non-exchangeable protons, thus TBA lacked the chair conformation 
whereas K+ profoundly changed the conformation to the chair fold. 
This was shown to occur in a sequential 1:2 TBA to K+ stoichiome-
try with greatly differing binding strengths, with the first binding 
site being between the TT loops Fig. (5b) and the second adjacent 
to the TGT loop Fig. (5c) [81]. Afterwards, it was discovered that 
Pb2+ is more potent in inducing the TBA fold and showed a 1:1 
stoichiometry as compared to K+ [84]. The same group later pro-
vided evidence that the Pb2+ binding site was between the two quar-
tets Fig. (5a) [85]. A further study of the structure of the potassium 
TBA complex by NMR confirmed the necessity for K+ in the chair 
type folding of TBA as had been claimed in the past [5, 6, 49]. It 
was also found that the first binding K+ is sufficient for chair fold 
formation and the second K+ that binds with increased concentra-
tion influences the TGT loop specifically.  
 More recently, a comparison between NH4
+, K+ and Na+ ions in 
terms of their localization within TBA was evaluated by NMR and 
other spectroscopic methods and conflicting conclusions were made 
about topological and stoichiometric aspects [86]. The topology 
formed in the presence of NH4
+ was similar to K+, Sr+, and Pb+ 
[86]. More importantly, binding between the two G-quadruplexes 
with the carbonyl oxygens was argued to be the location for these 
ions rather than between TT loops or adjacent to the TGT loop Fig. 
(5). Out of plane bending of G2 and G11 was seen, which supports 
the argument for inter-quartet localization. A unimolecular fold at a 
wide range of K+ concentrations was also seen which contrasts with 
Marathias and Bolton [49]. Also importantly, a unimolecular fold 
was seen at a wide range of K+ concentrations in contrast to two 
previously mentioned reports [44, 64]. It was also concluded that 
Na+ ions induce a fold that consists of heterogeneous structures, but 
fell short of describing Na+ location. This article claimed that be-
cause of an intra-quartet association of NH4
+ in TBA, and previous 
suggestions of the same localization of Pb2+ and Sr2+, that K+ is 
likely to localize similarly [85, 87]. As for the putative location of 
Na+, work in the past with telomeric sequences has been most con-
clusive and asserts the smaller Na+ ion lies in the intraplanar posi-
tion as illustrated in Fig. (5d) [88].  
 One interesting approach to detecting the folding and unfolding 
of G-quadruplex aptamers is the employment of nanopores [89]. 
Granted with the proper size and function, a nanopore can allow 
unfolded DNA to pass, and folded DNA to be retained. The resul-
tant current blockage can be measured and discrimination of folded 
vs. unfolded G-quadruplex based on kinetic properties can be 
achieved. In this study it was determined that K+, Ba2+, NH4
+ favor 
TBA folding over Cs+, Na+, Li+, Mg2+, and Ca2+. Interestingly, the 
Na+ folds and unfolds most rapidly and K+ has a slow unfolding 
reaction, which implies an ephemeral interaction with Na+. In an-
other example in which several different cations were examined, 
the effects on the conformation, unfolding, complex formation, and 
molar volume were assessed with CD, DSC, ITC, density and 
acoustical techniques [87]. K+, Rb+, NH4
+, Sr2+, and Ba2+ were 
found to form stable intramolecular complexes above 25oC, while 
Li+, Na+, Cs+, Mg2+, and Ca2+ were found to form weak complexes 
at low temperatures. The results were noted to coincide with the 
atomic radii of the cations. 
 A mass spectrometric approach, Electrospray Ionization (ESI), 
has also proved a viable way to detect the formation of G-
quadruplex in gas phase along with bound cations [90]. Asking if 
metal ion binding is specific, adenine substituted TBA was used as 
a control. Li+, Na+, K+, and Cs+ ions were found to bind to the con-
trols, however, enhanced adduct formation for K+ as opposed to the 
control implied specific binding. The ions which showed enhanced 
binding compared to control – Sr2+, Pb2+, Ba2+, and K+ - agree with 
the Kankia et al. correlation of ionic radii to G-quadruplex binding 
[87]. In contrast, a 2010 report employed ESI, sequencing with 
infared multiphoton dissociation (IRMPD), and CD to a TBA study 
investigating binding modes of K+, Na+, Rb+, and Cs+ [80]. IRMPD 
is able to sequence TBA by the breaking of the phosphate backbone 
in order to deduce ion association based on the fragments. This 
work concluded that K+ is first positioned in between the two TT 
loops and the second (1:2) K+ positions adjacent to the TGT loop as 
proposed by Marathias et al. Fig. (5) [49]. The significantly higher 
binding strength of K+ as compared to other cations was also con-

































Fig. (5). Tentative locations for cations in DNA aptamer G-quadruplexes. a: 
interplanar, b: subplanar, c: supersubplanar, d: intraplanar.  
 
 In order to determine TBA’s ability to fold into an anti-parallel 
intramolecular structure in the absence of a stabilizing cation, CD 
studies were performed in conditions of low temperature, molecular 
crowding, and thrombin as opposed to K+ [69]. In this study, Na+ 
was found to induce quadruplex formation at 4oC but hardly induce 
formation at 25oC. Quartet formation was induced by molecular 
crowding with PEG 200 as well as with thrombin alone. It was 
proposed however, that TBA has low inhibitory activity without K+ 
[69, 91]. Finally, in a study which defined some of the factors that 
favor the G-quadruplex fold, different cosolvents and solutes were 
added to TBA environment [92]. This article showed that solutes 
which decrease DNA duplex stability have an opposite effect for 
8    Current Pharmaceutical Design, 2012, Vol. 18, No. 00 Tucker et al. 
quadruplex formation, and the dielectric constants of the solvents 
have a large impact on stability, which would be consistent with 
cation-induced stability. 
G-QUADRUPLEX DNA APTAMER THERAPEUTIC AP-
PLICATIONS 
 The majority of aptamers developed for therapeutics are not 
necessarily G-quadruplex. The reader interested in therapeutic ap-
tamers generally including the most successful of the class Pegap-
tanib/Macugen used clinically is pointed to a recent review [93]. In 
the section below we focus on therapeutic DNA G-quadruplex ap-
tamers specifically. 
G-quadruplex DNA Aptamers Against Infective Agents 
 A major class of therapeutic G-quadruplex DNA aptamers 
against infective agents are those against HIV. In an early study, a 
library of all possible octanucleotide phosphorothioate sequences 
was screened and d(TTGGGGTT) was found as an inhibitor of HIV 
infection that acts by binding to envelope protein Gp120 thereby 
inhibiting cell-to-cell and virus-to-cell infection [22]. Size-
exclusion chromatography revealed that the oligonucleotide was 
tetrameric, and circular dichroism suggested that the phos-
phorothioate adopted a parallel G-quadruplex structure [22]. The 
aptamer was shown to have synergistic anti-HIV effects together 
with AZT against HIV in human cell lines [94]. Various hexanu-
cleotides, based around the d(TGGGAG) Hotoda sequence also 
exhibited strong anti-HIV properties [23, 95, 96]. A particularly 
exciting extension of these ideas are to use anti-gp120 aptamers 
(although in this case 2'F-substituted RNA aptamers) to deliver 
siRNA into HIV infected cells [97]. 
 Subsequently, an aptamer consisting only of deoxyguanosine 
and thymidine was shown to strongly inhibit HIV integrase with an 
IC50 in the nanomolar range [98]. Sequence change derivatives 
revealed that loop-ion interactions were critical for stability and 
inhibitory activities against the HIV integrase, and also resulting in 
an aptamer more stable than the closely related thrombin binding 
aptamer [99]. Further structure-activity studies using NMR and 
molecular modeling showed that the K+-bound form as an antiparal-
lel intramolecular fold with a pair of G-quadruplexes was critical to 
inhibitory activities [100]. DNA aptamers which were derived from 
aptamers against HIV-1 RNase H domain of reverse transcriptase 
inhibitors, which share a similar topological organization, were also 
shown to inhibit the HIV integrase [101]. These aptamers were later 
shown to adopt a stable dimeric G-quadruplex structure in the pres-
ence of potassium ions [24].  
 The HIV reverse transcriptase has also been targeted with DNA 
aptamers by a number of independent groups. Although the first 
SELEX experiments of DNA against reverse transcriptase did iden-
tify G-rich aptamers [102], it was not proven at that time whether 
they were indeed G-quadruplexes. More recent studies did identify 
related aptamers to be G-quadruplex [26]. DNA thioaptamers se-
lected against reverse transcriptase were identified with a KD of 70 
nM which also inhibited HIV replication in cell culture [103]. In yet 
another selection, DNA aptamers were found with a distinct run of 
seven guanosines near the 3’ end of the aptamer which were neces-
sary and sufficient for tight binding [104, 105]. Capillary electro-
phoresis identified DNA aptamers that bind even tighter to reverse 
transcriptase (180 pM), though the aptamers were heterogeneous 
and not necessarily G-quadruplex [106]. 
 DNA aptamers were isolated against the Hepatitis C Virus 
(HCV) RNA-dependent RNA polymerase (RdRp) and observed to 
be particularly G-rich [28]. The aptamers inhibited polymerase 
activity in the nanomolar range, and were highly specific to the 
HCV subtype 3a polymerase without inhibiting the HCV subtype 
1a or 1b polymerases. Other aptamers selected against the same 
target did not show G-quadruplex structure [107, 108].  
 A study selecting aptamers against the SARS coronavirus heli-
case showed that both G-quadruplex and non-G-quadruplex aptam-
ers were identified in the same selection procedure [14]. The non-
G-quadruplex did inhibit helicase activities, whereas the G-
quadruplex aptamers did not, implying a clear structure-function 
relationship between the G-quadruplex nature of the aptamer and its 
inhibitory activities.  
 Aptamers have been selected against polyphosphate kinase 2 
from Mycobacterium tuberculosis and both G-quadruplex and non-
G-quadruplex DNA aptamers were identified [13]. Mutational 
analysis revealed that the G-quadruplex motif was essential for 
inhibition. Aptamers against MPT64 were found to have several 
consecutive G-rich sequences suggesting these may also have G-
quadruplex structure [109].  
G-quadruplex DNA Aptamers to Control Coagulation 
 We have discussed the thrombin-binding aptamers in much 
detail in terms of dissecting the structure of the thrombin-aptamer 
complex in the sections above. A recent review has recapped pro-
gress with regards to clinical trials for nucleic acid aptamers gener-
ally as antithrombotic agents [110], incorporating aptamers against 
a variety of targets that are not necessarily G-quadruplex and hence 
beyond the scope of this review. The thrombin-binding aptamer 
itself was halted after Phase I clinical trials, but the many variations 
such as all the chemical modifications discussed prior and/or biva-
lency [111] may prove more effective. 
G-quadruplex DNA Aptamers for Cancer 
 AS1411 is a G-quadruplex DNA aptamer that is undergoing 
Phase II clinical trials as an anticancer agent, for renal cell carci-
noma and myeloid leukemia. The discovery of AS1411 was to an 
extent coincidental – a result of using the “purine motif” approach 
of using triplex-forming oligodeoxynucleotides to modulate gene 
expression [112]. This led to sequences consisting entirely of gua-
nine and thymine, one of which was a 26-mer that became 
AGRO100 while being developed at Aptamera, then was renamed 
as AS1411 after acquisition by Antisoma. In May 2011, AS1411 
was acquired by Advanced Cancer Therapeutics (ACT), and re-
named ACT-GRO-777. AS1411 binds to both nucleolin and to 
nuclear factor-kB essential modulator (NEMO), which is involved 
in activation of the critical transcription factor NK-kB [113]. Phase 
I clinical trials were completed in 2006 (a total of 30 patients) 
[112], with Phase II trials against acute myeloid leukemia showing 
positive interim data. Recent research has extended the use of 
AS1411 as a carrier for the delivery of cancer drugs specifically 
into cancer cells by nucleolin mediated internalization [114].  
 Signal transducer and activator of transcription (Stat3) is an 
oncogene that is activated in many human cancers. A G-quadruplex 
aptamer was found to inhibit DNA binding activity of Stat3 with an 
IC50 of 7 μM [115]. Furthermore, the G-quadruplex aptamer was 
delivered efficiently to the cytoplasm and nucleus, and was shown 
to suppress Stat3 oncogenic pathways. These G-quadruplexes were 
further developed and shown to suppress tumor growth in a non-
small cell lung cancer model in mice [18]. 
G-quadruplex DNA Aptamers for Skeletal Disease 
 Sclerostin is an extracellular negative regulator of bone growth 
that is major therapeutic target for osteoporosis. Parallel to a variety 
of efforts to develop antibodies against sclerostin (which recently 
completed Phase II clinical trials), DNA aptamers were also se-
lected against sclerostin as an alternative approach and found to 
have parallel G-quadruplex structure [12]. These aptamers were 
effective in a cell culture model to inhibit sclerostin's antagonistic 
effect on Wnt signaling, and are under further development as an 
alternative approach to inhibiting sclerostin for skeletal disease. 
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G-QUADRUPLEX DNA APTAMER DIAGNOSTIC, DETEC-
TION AND SENSING APPLICATIONS 
 The G-quadruplex plays a significant role in mediated analyte 
detection by aptamers, which are commonly referred to as aptasen-
sors. As recently as 2010 aptasensors were reviewed in the context 
of label and substrate free systems and nucleic acid nanostructures 
and machines were reviewed as well [116, 117]. Most recently, a 
review focused on aptamer based detection with excellent descrip-
tions of the technical assay strategies associated with this approach 
[118]. However, design and use of aptasensors in the context of the 
G-quadruplex itself has not been summarized and therefore we 
integrate several recent papers here. 
 Important to the topic of aptasensor systems is the use of metal-
lic beads, electrodes, and quantum dots which enable more sensitiv-
ity over colorimetric systems and allow for signal amplification 
schemes. One important development is the use of a horseradish 
peroxidase (HRP) mimicking DNAzyme system whereby the iron 
containing porphyrin hemin binds to an 18 base pair, K+ dependent 
aptamer d(GTGGGTAGGGCGGGTTGG) which was selected 
against N-methylmesoporphyrin IX [32]. Hemin’s inherent peroxi-
dase activity was then found to significantly increase when in com-
plex with the aptamer, hence HRP mimicking DNAzyme was in-
troduced [32]. It was later realized that the RNA version of PS2.M 
(rPS2.M) also showed enhanced peroxidase activity, demonstrating 
that RNA counterpart aptamers can have similar structure and func-
tion [119]. The intramolecular guanines were also shown to play an 
important role in the peroxidase activity [120]. Later, the structural 
and stability properties of PS2.M were further studied with spectro-
scopic methods and NMR [121]. This work revealed that Na+ and 
Pb2+ induce unimolecular structures but the presence of K+ forms 
both unimolecular and multistranded types. It was concluded that 
one Pb2+ cation confers the three quadruplex fold, and the active 
complex in the presence of K+ may result from a multistranded 
parallel type structure.  
 Because of its biological significance, thrombin has been the 
analyte in many assays, some of which employ the HRP mimicking 
DNAzyme. In two such examples which detected thrombin in the 
nanomolar range, metallic nanoparticles were used in the detection 
scheme [122, 123]. These strategies linked TBA to PS2.M in some 
way such that peroxidase activity was affected upon thrombin bind-
ing. More complicated schemes based on the initial event of the 
TBA folding upon thrombin binding have also been used [124]. 
One interesting approach involves a TBA and hemin complex 
which also possesses some peroxidase activity [125]. The chair 
conformation supported by the presence of K+ was shown to have a 
weak interaction with hemin, but in the presence of thrombin the 
interaction changed so that peroxidase activity was significantly 
higher, allowing colorimetric detection at 20 nM substrate. In an-
other similar example in which TBA itself binds hemin to enhance 
peroxidase activity, thiamine reduction was exploited for a fluores-
cence signal enabling a detection limit in the picomolar range [126].  
 Alternatively, a few thrombin detection schemes do not employ 
peroxidase activity but rely on quadruplex formation changing 
atomic proximities thus leading to a signal. Recently, a 50 nM de-
tection of thrombin using fluorescence quenching also used CD to 
confirm quadruplex formation in the process [127]. Furthermore, 
electrochemical detection has recently detected thrombin using gold 
electrodes [128, 129] and gold nanoshells [130]. In one strategy, 
thrombin binding and quartet formation leads to dissociation of 
double stranded DNA thus freeing a quenched fluorescent label 
[129]. The gold nanoshell approach uses Raman spectroscopy in a 
label free, direct measurement [130]. Raman spectroscopy senses 
the sugar pucker conformation, thus further emphasizing its impor-
tance to the G-quadruplex. Apart from thrombin, the cancer-
associated nucleolin protein and an HIV-1 integrase have also been 
detected with aptamers AS1411 and T30695, respectively, while 
making use of their own peroxidase activity [131]. AS1411, which 
binds HeLa cell expressed surface nucleolin, was used for in situ 
sensing. This work also importantly asserts that AS1411 requires 
K+ for folding while cations actually inhibit T30695 quadruplex 
formation. Further structural and stability work on these aptamers 
would offer a needed comparison to the better characterized TBA. 
 Regarding small molecules, adenosine, AMP, and ATP have 
also been the analyte in some recent assays. Adenosine is key to 
kidney function [132] and has been associated with cancer [133]. 
The initial selection of the adenosine/ATP aptamer used sequence 
substitutions and nucleotide analogues to demonstrate G-quartet 
formation [35]. Upon sequence comparison, a two quartet structure 
similar to TBA was observed, although with longer loop regions 
which include a hairpin on one end and a duplex on the other [35]. 
In one example of adenosine detection, an anti-flavin adenine 
dinucleotide-dependent glucose dehydrogenase (FADGDH) ap-
tamer was attached to a scaffold containing the adenosine aptamer 
[134]. Upon binding of adenosine, quartet formation brings 
FADGDH closer to the electrode to confer a signal. In a similar 
strategy, quartet formation upon adenosine binding used gold nano-
rods and Plasmon Resonance Absorption (PRA) was monitored to 
detect analytes in the low nM range in rat brain tissue [135]. Simi-
larly, adenosine binding aptamer (Aptado) and platelet derived 
growth factor (PDGF) binding aptamer (AptPDGF) were used to bind 
adenosine and boost signal respectively [136]. Here, folded (Aptado) 
displaces unfolded (Aptado) on the surface of gold nanoparticle oli-
green labeled oligos. Further, two recent strategies use a 
PS2.M/hemin HRP mimetic system in conjunction with the adeno-
sine aptamer [137, 138]. In one, a complicated system of “logic 
gates” allows for the biocatalytic regulation of thrombin activity 
with inputs such as ATP or cocaine [137]. In a more simple exam-
ple, a duplex using (Aptado) dissociates upon adenosine binding 
which causes gold nanoparticle aggregation [139]. Finally, detec-
tion of adenosine deamidase activity was achieved by allowing 
conversion of adenosine to inosine to confer a flexible structure 
freeing hemin and K+ thus forming a separate quadruplex for an 
electrochemical response [140]. 
 DNA sequences have also been a target for some recent detec-
tion strategies. Again, exploiting the fact that quadruplexes form 
only under certain conditions, hairpin DNA structures in a “caged” 
form containing the sequence for a particular aptamer are forced 
into folding upon analyte binding, which is the case in a recent 
method to detect DNA, AMP, and Hg2+ [141]. DNA, AMP and 
glucose were also detected recently in a similar manner by the same 
group [142]. In an interesting PCR based approach, “padlock 
probes” that straddle single nucleotide polymorphisms (SNPs) were 
ligated, amplified, and introduced to hemin to confer G-quartet in 
HRP-mimicking DNAzyme thus giving rise to signal [124]. The 
HRP DNAzyme system was also used in a way in which PS2.M 
was extended with sequences complementary to a target such that 
the PS2.M quadruplex would form upon a nucleotide mismatch 
[143]. HRP DNAzyme was also used in a system using quantum 
dots that allow for a multiplex detection of different DNA se-
quences using chemiluminescence resonance energy transfer 
(CRET)[144]. Hg2+ and ATP were also detected using this 
system[144]. Some small molecules have also been targeted re-
cently which including hemin itself based on the PS2.M system 
[145]. Ochratoxin, a mycotoxin found in foods, was detected with 
ochratoxin aptamer [33] immobilized on gold nanoparticles [146]. 
Ochratoxin aptamer forms quadruplexes upon ligand binding, 
which was exploited to aggregate gold nanoparticles for 
detection[146]. 
 Regarding aptamer-mediated cation detection, K+ has been 
detected using a designed K+ binding quartet forming sequence [34] 
in which nanosilver aggregates upon quartet formation [77] and by 
displacement of K+ from the quadruplex sequence by a complemen-
tary strand [76]. This method was also used for DNA sequence 
detection. Pb2+ has also been a target analyte based on the PS2.M 
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system whereby the stable K+ and hemin bound aptamer is dis-
rupted by Pb2+, thereby abrogating peroxidase activity [147]. 
FUTURE PERSPECTIVES 
 It has now been over two decades since the original pioneering 
nucleic acid aptamer selections. As the original patents for the SE-
LEX process expire, there will likely be a reinvigoration of aptamer 
research with therapeutic and diagnostic ambitions [148, 149]. As 
such, selection of aptamers against new targets will no doubt lead to 
an increasing diversity of DNA G-quadruplex aptamers over com-
ing years.  
 The structure of the thrombin binding aptamer–thrombin com-
plex has been particularly instructional to elucidate folds, ion bind-
ing, grooves and binding mechanisms of G-quadruplex aptamers. 
However, we critically need high-resolution structures of other G-
quadruplex aptamers in complex with their targets to answer the 
question of whether TBA is typical or atypical, and to help us an-
swer the question of how G-quadruplex aptamers manage such high 
target specificities and binding affinities. New structures will help 
G-quadruplex aptamers meet their therapeutic promise and analyti-
cal potential, leading to a new chapter in DNA G-quadruplex ap-
tamer research.  
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